Dergiler / Turkish archives of pediatrics (Online) / 2022 / Cilt: 57 - Sayı: 1

Evaluation of Tubular Dysfunction Using Urine Biomarkers in Children with COVID-19

Sayfa
99–103
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

We believe that these findings contribute to the accumulation of evidence on continued inflammation in the kidney.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: The coronavirus disease pandemic is a major problem that the world has been facing since December 2019.
📊
Temel Bulgular & Veri:Materials and Methods: We included 36 children who tested positive for severe acute respiratory syndrome coronavirus 2 on real-time reverse transcriptase-polymerase chain reaction using respiratory specimens.
💡
Sonuç & Katkı:We believe that these findings contribute to the accumulation of evidence on continued inflammation in the kidney.
🔬Tür:Araştırma Makalesi
📍Kapsam:2019 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Objective: The coronavirus disease pandemic is a major problem that the world has been facing since December 2019. It mainly affects the respiratory system; however, the disease can affect the kidneys to different degrees. This study aimed to determine the changes in tubular dysfunction and inflammation parameters in children with coronavirus disease using urine biomarkers. Materials and Methods: We included 36 children who tested positive for severe acute respiratory syndrome coronavirus 2 on real-time reverse transcriptase-polymerase chain reaction using respiratory specimens. Coronavirus disease-positive and -negative period parameters were evaluated. For measurement of interleukin-1β, interleukin-6, and urine β2 microglobulin levels, patients’ urine samples were collected at diagnosis and 1 month after discharge. Additionally, routine urine and hematological parameters were evaluated concurrently. Results: For all patients, the median urine β2 microglobulin, serum urea, and lactate dehydrogenase levels were significantly higher in the coronavirus disease-positive period than in the coronavirus disease-negative period (P .05). Conclusion: Our results suggest kidney involvement and tubular dysfunction in patients with asymptomatic, mild, and moderate infections. Furthermore, interleukin-1β and interleukin-6 levels were high in the urine, even in non-critically ill patients. We believe that these findings contribute to the accumulation of evidence on continued inflammation in the kidney.

🔖

Bu Makaleye Atıf Yap

TAŞ, N., GÖKÇEOĞLU, A. U., AYKAÇ, K., YAYLA, B. C. C., ŞENES, M., DEMİRKAPI, L., SAMSUN, E. Ç. (2022). Evaluation of Tubular Dysfunction Using Urine Biomarkers in Children with COVID-19. Turkish archives of pediatrics (Online), Cilt: 57 - Sayı: 1, 99–103. https://ajindex.com/articles/414179

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Aygün D, Önal P, Apaydın G, Çokuğraş H. Coronavirus infections in childhood and vaccine studies. Turk Arch Pediatr. 2021
  2. 56(1):10- 14. [CrossRef] 2. Chen X, Zhao B, Qu Y, et al. Detectable serum severe acute respiratory syndrome coronavirus 2 viral load (RNAemia) is closely correlated with drastically elevated interleukin 6 level in critically ill patients with coronavirus disease 2019. Clin Infect Dis. 2020
  3. 71(8):1937-1942. [CrossRef] 3. Huart J, Bouquegneau A, Lutteri L, et al. Proteinuria in COVID-19: prevalence, characterization and prognostic role. J Nephrol. 2021
  4. 34(2):355-364. [CrossRef] 4. Gabarre P, Dumas G, Dupont T, Darmon M, Azoulay E, Zafrani L. Acute kidney injury in critically ill patients with COVID-19. Intensive Care Med. 2020
  5. 46(7):1339-1348. [CrossRef] 5. Wang X, Chen X, Tang F, et al. Be aware of acute kidney injury in critically ill children with COVID-19. Pediatr Nephrol. 2021
  6. 36(1):163- 169. [CrossRef] 6. Stewart DJ, Hartley JC, Johnson M, Marks SD, du Pré P, Stojanovic J. Renal dysfunction in hospitalised children with COVID-19. Lancet Child Adolesc Health. 2020
  7. 4(8):e28-e29. [CrossRef] 7. Kimball ES, Pickeral SF, Oppenheim JJ, Rossio JL. Interleukin 1 activity in normal human urine. J Immunol. 1984
  8. 133(1):256-260. 8. Liao Z, Grimshaw RS, Rosenstreich DL. Identification of a specific interleukin 1 inhibitor in the urine of febrile patients. J Exp Med. 1984
  9. 159(1):126-136. [CrossRef] 9. Marcon L, Fritz ME, Kurman CC, Jensen JC, Nelson DL. Soluble Tac peptide is present in the urine of normal individuals and at elevated levels in patients with adult T cell leukaemia (ATL). Clin Exp Immunol. 1988
  10. 73(1):29-33. 10. Novick D, Engelmann H, Wallach D, Rubinstein M. Soluble cytokine receptors are present in normal human urine. J Exp Med. 1989
  11. 170(4):1409-1414. [CrossRef] 11. Engelmann H, Novick D, Wallach D. Two tumor necrosis factorbinding proteins purified from human urine: evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. J Biol Chem. 1990
  12. 265(3):1531-1536. [CrossRef] 12. Noble B, Ren K, Taverne J, et al. Mononuclear cells in glomeruli and cytokines in urine reflect the severity of experimental proliferative immune complex glomerulonephritis. Clin Exp Immunol. 1990
  13. 80(2):281-287. [CrossRef] 13. Ohta K, Takano N, Seno A, et al. Detection and clinical usefulness of urinary interleukin-6 in the diseases of the kidney and the urinary tract. Clin Nephrol. 1992
  14. 38(4):185-189. 14. Iwano M, Dohi K,